Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of…
NCT00466869 · OBEcure Ltd., Industry · Terminated
Key facts
| NCT number | NCT00466869 |
|---|---|
| Title | A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effect of Betahistine on Plasma Lipids in Patients Treated With Simvastatin |
| Lead sponsor | OBEcure Ltd., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Betahistine |
| Enrollment | 30 |
| Start date | May 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Apr 27, 2007 |
| Last update posted | Sep 26, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: